Typhoon Noul, China's strongest storm this year, made landfall in Guangdong, cancelling flights and rail services and stranding 2,000 at Hong Kong airport.
The killing of a dog and her puppies in Guangdong has spurred China's animal rights advocates to move their campaign offline and overseas amid censorship.
New World Development's Pavilia Farm III luxury project in Hong Kong sells out its first phase of 88 flats for HK$950 million in a single day, despite prior rebuilding costs.
Canadian PM Mark Carney accused Trump of trying to destroy Canada's auto industry and set conditions for resuming trade talks after negotiations broke down
The US Supreme Court on Monday lifted an injunction blocking Trump's mail voting restrictions across 23 states and Washington, DC, ahead of the midterms.
Abercrombie & Fitch shares jumped 37% Wednesday after a roughly $100 million tariff refund, raised guidance and a 15th straight quarter of sales growth.
Anthropic will pay Nscale $45 billion to rent about 460 megawatts of AI compute at a West Virginia data center, according to a report published August 26.
Thieves stole four Renaissance paintings by Antonello da Messina from a Sicilian museum overnight without triggering alarms, prompting a professional-heist
Thai elephant parks, including Maetaeng Elephant Park & Clinic, are facing a significant decline in tourist numbers due to global travel disruptions and uncertainty stemming from the Middle East conflict.
A consortium including Jeff Bezos and Eduardo Saverin has agreed to buy a minority stake in Liverpool, valuing the Premier League club at around $6 billion
LIV Golf has secured a new lead investor to operate without Saudi funding while giving players equity, CEO Scott O'Neil announced, with a September close t
Hims & Hers CEO Andrew Dudum has pushed back against an FTC lawsuit, arguing regulators misunderstand the telehealth company's disruptive business model.
CVS Health topped earnings estimates and raised its annual profit forecast on stronger drug revenues, unveiling a new Eli Lilly collaboration for Zepbound
Eli Lilly lifted its full-year revenue forecast as surging Mounjaro and Zepbound sales widened its lead over Novo Nordisk in the weight-loss drug market.
